{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:32:47Z","timestamp":1793658767142,"version":"4.5.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13346-025-02032-2","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:43:24Z","timestamp":1767717804000},"page":"2883-2910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomimetic platelet-membrane camouflaged ivermectin nanocrystals for tumor homing and breast cancer management"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8527-8789","authenticated-orcid":false,"given":"Marwa M.","family":"Sheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-5049","authenticated-orcid":false,"given":"Salma E.","family":"El-Habashy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9018-5229","authenticated-orcid":false,"given":"Eman","family":"Sheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M. A.","family":"Nasra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama Y.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"7","key":"2032_CR1","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s00436-021-07172-1","volume":"120","author":"DA Elmehy","year":"2021","unstructured":"Elmehy DA, Hasby Saad MA, El Maghraby GM, Arafa MF, Soliman NA, Elkaliny HH, et al. Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice. Parasitol Res. 2021;120(7):2641\u201358.","journal-title":"Parasitol Res"},{"key":"2032_CR2","unstructured":"The 2015 nobel prize in physiology or medicine. 2015 31\/7\/2025]. Available from: https:\/\/www.nobelprize.org\/prizes\/medicine\/2015\/press-release\/."},{"issue":"4","key":"2032_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/ph15040445","volume":"15","author":"O Delandre","year":"2022","unstructured":"Delandre O, Gendrot M, Jardot P, Le Bideau M, Boxberger M, Boschi C, et al. Antiviral activity of repurposing ivermectin against a panel of 30 clinical SARS-CoV-2 strains belonging to 14 variants. Pharmaceuticals. 2022;15(4):445.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2032_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00011-011-0307-8","volume":"60","author":"S Yan","year":"2011","unstructured":"Yan S, Ci X, Chen N, Chen C, Li X, Chu X, et al. Anti-inflammatory effects of ivermectin in mouse model of allergic asthma. Inflamm Res. 2011;60(6):589\u201396.","journal-title":"Inflamm Res"},{"issue":"5","key":"2032_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ja.2017.11","volume":"70","author":"A Crump","year":"2017","unstructured":"Crump A. Ivermectin: enigmatic multifaceted \u2018wonder\u2019drug continues to surprise and exceed expectations. J Antibiot (Tokyo). 2017;70(5):495\u2013505.","journal-title":"J Antibiot (Tokyo)"},{"key":"2032_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S237393","author":"J Liu","year":"2020","unstructured":"Liu J, Zhang K, Cheng L, Zhu H, Xu T. Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin. Drug Des Devel Ther. 2020. https:\/\/doi.org\/10.2147\/DDDT.S237393.","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"2032_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076446","volume":"24","author":"C Stolfi","year":"2023","unstructured":"Stolfi C, Pacifico T, Luiz-Ferreira A, Monteleone G, Laudisi F. Anthelmintic drugs as emerging immune modulators in cancer. Int J Mol Sci. 2023;24(7):6446.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2032_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111466","volume":"16","author":"EM Steenekamp","year":"2024","unstructured":"Steenekamp EM, Liebenberg W, Lemmer HJ, Gerber M. Formulation and ex vivo evaluation of ivermectin within different nano-drug delivery vehicles for transdermal drug delivery. Pharmaceutics. 2024;16(11):1466.","journal-title":"Pharmaceutics"},{"key":"2032_CR9","first-page":"71","volume-title":"Nanoparticulate drug delivery systems","author":"J M\u00f6schwitzer","year":"2007","unstructured":"M\u00f6schwitzer J, M\u00fcller RH. Drug nanocrystals\u2014the universal formulation approach for poorly soluble drugs. In: Nanoparticulate drug delivery systems. CRC Press; 2007. p. 71\u201388."},{"issue":"15","key":"2032_CR10","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-15-2887","volume":"76","author":"Q Dou","year":"2016","unstructured":"Dou Q, Chen H-N, Wang K, Yuan K, Lei Y, Li K, et al. Ivermectin induces cytostatic autophagy by blocking the PAK1\/Akt axis in breast cancer. Cancer Res. 2016;76(15):4457\u201369.","journal-title":"Cancer Res"},{"key":"2032_CR11","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.4c00314","author":"K Aloss","year":"2024","unstructured":"Aloss K, Leroy Viana PH, Bokhari SMZ, Giunashvili N, Schvarcz CA, B\u00f3csi D, et al. Ivermectin synergizes with modulated electro-hyperthermia and improves its anticancer effects in a triple-negative breast cancer mouse model. ACS Pharmacol Transl Sci. 2024. https:\/\/doi.org\/10.1021\/acsptsci.4c00314.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2032_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11705-015-1509-3","volume":"9","author":"T-L Chang","year":"2015","unstructured":"Chang T-L, Zhan H, Liang D, Liang JF. Nanocrystal technology for drug formulation and delivery. Front Chem Sci Eng. 2015;9:1\u201314.","journal-title":"Front Chem Sci Eng"},{"issue":"1","key":"2032_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-020-0184-8","volume":"24","author":"S Jacob","year":"2020","unstructured":"Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24(1):3.","journal-title":"Biomater Res"},{"key":"2032_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.030","volume":"183","author":"VK Pawar","year":"2014","unstructured":"Pawar VK, Singh Y, Meher JG, Gupta S, Chourasia MK. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014;183:51\u201366.","journal-title":"J Control Release"},{"key":"2032_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111185","author":"P Lhaglham","year":"2024","unstructured":"Lhaglham P, Jiramonai L, Jia Y, Huang B, Huang Y, Gao X, et al. Drug nanocrystals: surface engineering and its applications in targeted delivery. iScience. 2024. https:\/\/doi.org\/10.1016\/j.isci.2024.111185.","journal-title":"iScience"},{"issue":"1","key":"2032_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20(1):33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"2032_CR17","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/pharmaceutics13111888","volume":"13","author":"L Tang","year":"2021","unstructured":"Tang L, He S, Yin Y, Liu H, Hu J, Cheng J, et al. Combination of nanomaterials in cell-based drug delivery systems for cancer treatment. Pharmaceutics. 2021;13(11):1888.","journal-title":"Pharmaceutics"},{"issue":"4","key":"2032_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s11705-017-1614-6","volume":"11","author":"Q Hu","year":"2017","unstructured":"Hu Q, Bomba HN, Gu Z. Engineering platelet-mimicking drug delivery vehicles. Front Chem Sci Eng. 2017;11(4):624\u201332.","journal-title":"Front Chem Sci Eng"},{"key":"2032_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177202","volume":"988","author":"L Xu","year":"2025","unstructured":"Xu L, Xu P, Wang J, Ji H, Zhang L, Tang Z. Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment. Eur J Pharmacol. 2025;988:177202.","journal-title":"Eur J Pharmacol"},{"key":"2032_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","volume":"105","author":"C-H Xu","year":"2020","unstructured":"Xu C-H, Ye P-J, Zhou Y-C, He D-X, Wei H, Yu C-Y. Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy. Acta Biomater. 2020;105:1\u201314.","journal-title":"Acta Biomater"},{"issue":"11","key":"2032_CR21","doi-asserted-by":"publisher","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","volume":"15","author":"V Chugh","year":"2021","unstructured":"Chugh V, Vijaya Krishna K, Pandit A. Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation. ACS Nano. 2021;15(11):17080\u2013123.","journal-title":"ACS Nano"},{"key":"2032_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","volume":"76","author":"J Li","year":"2016","unstructured":"Li J, Ai Y, Wang L, Bu P, Sharkey CC, Wu Q, et al. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials. 2016;76:52\u201365.","journal-title":"Biomaterials"},{"key":"2032_CR23","volume":"6","author":"H Awad","year":"2023","unstructured":"Awad H, Rawas-Qalaji M, El Hosary R, Jagal J, Ahmed IS. Formulation and optimization of ivermectin nanocrystals for enhanced topical delivery. Int J Pharm: X. 2023;6:100210.","journal-title":"Int J Pharm: X"},{"issue":"6","key":"2032_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/10837450.2016.1200078","volume":"22","author":"WJ Starkloff","year":"2017","unstructured":"Starkloff WJ, Bucal\u00e1 V, Palma SD, Gonzalez Vidal NL. Design and in vitro characterization of ivermectin nanocrystals liquid formulation based on a top\u2013down approach. Pharm Dev Technol. 2017;22(6):809\u201317.","journal-title":"Pharm Dev Technol"},{"key":"2032_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S139706","author":"AN Allam","year":"2017","unstructured":"Allam AN, Hamdallah SI, Abdallah OY. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo\/in vivo evaluation. Int J Nanomedicine. 2017. https:\/\/doi.org\/10.2147\/IJN.S139706.","journal-title":"Int J Nanomedicine"},{"key":"2032_CR26","doi-asserted-by":"crossref","unstructured":"Zheng H, Li J, Leung SSY. Inhalable polysorbates stabilized nintedanib nanocrystals to facilitate pulmonary nebulization and alveolar macrophage evasion. Biomater Adv 2024;214084.","DOI":"10.1016\/j.bioadv.2024.214084"},{"issue":"1","key":"2032_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1039\/C9RA09468G","volume":"10","author":"MA Farooq","year":"2020","unstructured":"Farooq MA, Li L, Parveen A, Wang B. Globular protein stabilized nanoparticles for delivery of disulfiram: fabrication, characterization, in vitro toxicity, and cellular uptake. RSC Adv. 2020;10(1):133\u201344.","journal-title":"RSC Adv"},{"issue":"20","key":"2032_CR28","doi-asserted-by":"publisher","first-page":"12620","DOI":"10.1021\/acsami.6b01680","volume":"8","author":"X Miao","year":"2016","unstructured":"Miao X, Li Y, Wang X, Lee SM-Y, Zheng Y. Transport mechanism of coumarin 6 nanocrystals with two particle sizes in MDCKII monolayer and larval zebrafish. ACS Appl Mater Interfaces. 2016;8(20):12620\u201330.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7571","key":"2032_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15373","volume":"526","author":"C-MJ Hu","year":"2015","unstructured":"Hu C-MJ, Fang RH, Wang K-C, Luk BT, Thamphiwatana S, Dehaini D, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118\u201321.","journal-title":"Nature"},{"issue":"32","key":"2032_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201900795","volume":"31","author":"G Liu","year":"2019","unstructured":"Liu G, Zhao X, Zhang Y, Xu J, Xu J, Li Y, et al. Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity. Adv Mater. 2019;31(32):1900795.","journal-title":"Adv Mater"},{"issue":"4","key":"2032_CR31","first-page":"980","volume":"57","author":"M Okazaki","year":"2020","unstructured":"Okazaki M, Yamaguchi T, Tajima H, Fushida S, Ohta T. Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis. Int J Oncol. 2020;57(4):980\u20138.","journal-title":"Int J Oncol"},{"key":"2032_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jconrel.2020.05.016","volume":"324","author":"D Mei","year":"2020","unstructured":"Mei D, Gong L, Zou Y, Yang D, Liu H, Liang Y, et al. Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy. J Control Release. 2020;324:341\u201353.","journal-title":"J Control Release"},{"issue":"1","key":"2032_CR33","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Bai X, Martikainen M-V, K\u00e5rlund A, Roponen M, Xu W, et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles. Nat Commun. 2021;12(1):5726.","journal-title":"Nat Commun"},{"issue":"11","key":"2032_CR34","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1007\/s12274-018-2126-5","volume":"11","author":"Y He","year":"2018","unstructured":"He Y, Li R, Liang J, Zhu Y, Zhang S, Zheng Z, et al. Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis. Nano Res. 2018;11(11):6086\u2013101.","journal-title":"Nano Res"},{"issue":"11","key":"2032_CR35","first-page":"3865","volume":"6","author":"T Zhang","year":"2021","unstructured":"Zhang T, Liu H, Li L, Guo Z, Song J, Yang X, et al. Leukocyte\/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo\/chemotherapeutic agents for triple negative breast cancer combination treatment. Bioact Mater. 2021;6(11):3865\u201378.","journal-title":"Bioact Mater"},{"key":"2032_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119097","volume":"578","author":"SM Etman","year":"2020","unstructured":"Etman SM, Abdallah OY, Mehanna RA, Elnaggar YS. Lactoferrin\/hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer. Int J Pharm. 2020;578:119097.","journal-title":"Int J Pharm"},{"issue":"1","key":"2032_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11481-024-10099-w","volume":"19","author":"SAA Morsy","year":"2024","unstructured":"Morsy SAA, Fathelbab MH, El-Sayed NS, El-Habashy SE, Aly RG, Harby SA. Doxycycline-loaded calcium phosphate nanoparticles with a pectin coat can ameliorate lipopolysaccharide-induced neuroinflammation via enhancing AMPK. J Neuroimmune Pharmacol. 2024;19(1):2.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2032_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104673","author":"S Nezhadi","year":"2023","unstructured":"Nezhadi S, Norouzi P, Rasouli A, Javar HA, Ostad SN, Dorkoosh F. Co-delivery of paclitaxel and regorafenib by F127\/TPGS mixed micelles for triple negative breast cancer treatment. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104673.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2032_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123163","volume":"642","author":"S Aly","year":"2023","unstructured":"Aly S, El-Kamel AH, Sheta E, El-Habashy SE. Chondroitin\/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy. Int J Pharm. 2023;642:123163.","journal-title":"Int J Pharm"},{"key":"2032_CR40","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S207589","author":"J Ye","year":"2019","unstructured":"Ye J, Yang Y, Dong W, Gao Y, Meng Y, Wang H, et al. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages. Int J Nanomed. 2019. https:\/\/doi.org\/10.2147\/IJN.S207589.","journal-title":"Int J Nanomed"},{"key":"2032_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124086","volume":"656","author":"FS Abou-Elnour","year":"2024","unstructured":"Abou-Elnour FS, El-Habashy SE, Essawy MM, Abdallah OY. Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured lipid carrier for synergistic antileukemia therapy. Int J Pharm. 2024;656:124086.","journal-title":"Int J Pharm"},{"key":"2032_CR42","doi-asserted-by":"crossref","unstructured":"Nour EM, El-Habashy SE, El-Bab AMF, Samy DM, Albanawany NM, El-Moslemany RM, El-Kamel AH. Mannose-tagged rhamnosomes for active targeting of pterostilbene in acute lung injury. J Drug Delivery Sci Technol 2025;106970.","DOI":"10.1016\/j.jddst.2025.106970"},{"issue":"1","key":"2032_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-824X-5-9","volume":"5","author":"J-W Gu","year":"2013","unstructured":"Gu J-W, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, et al. EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1\u03b1 and NF\u03baB, and VEGF expression. Vasc Cell. 2013;5(1):9.","journal-title":"Vasc Cell"},{"issue":"4","key":"2032_CR44","first-page":"385","volume":"5","author":"OM Rashid","year":"2013","unstructured":"Rashid OM, Nagahashi M, Ramachandran S, Dumur CI, Schaum JC, Yamada A, et al. Is tail vein injection a relevant breast cancer lung metastasis model? J Thorac Dis. 2013;5(4):385.","journal-title":"J Thorac Dis"},{"issue":"8","key":"2032_CR45","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","volume":"10","author":"H Cao","year":"2016","unstructured":"Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, et al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano. 2016;10(8):7738\u201348.","journal-title":"ACS Nano"},{"issue":"4","key":"2032_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejps.2010.04.006","volume":"40","author":"D Xia","year":"2010","unstructured":"Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation\u2013ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 2010;40(4):325\u201334.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2032_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.","journal-title":"Pharmaceutics"},{"issue":"2\u20133","key":"2032_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Alakhov VY. Pluronic\u00ae block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82(2\u20133):189\u2013212.","journal-title":"J Control Release"},{"key":"2032_CR49","doi-asserted-by":"publisher","first-page":"1122071","DOI":"10.3389\/fphar.2023.1122071","volume":"14","author":"W Zhao","year":"2023","unstructured":"Zhao W, Ruan B, Sun X, Yu Z. Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability. Front Pharmacol. 2023;14:1122071.","journal-title":"Front Pharmacol"},{"issue":"21","key":"2032_CR50","doi-asserted-by":"publisher","first-page":"8951","DOI":"10.1021\/la061122t","volume":"22","author":"ME Matteucci","year":"2006","unstructured":"Matteucci ME, Hotze MA, Johnston KP, Williams RO. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir. 2006;22(21):8951\u20139.","journal-title":"Langmuir"},{"key":"2032_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106805","volume":"107","author":"MK Anwer","year":"2025","unstructured":"Anwer MK, Mirza MA, Aleemuddin M, Alshdefat R. Enhanced cytotoxicity of osimertinib nanocrystals against lung cancer: preparation, characterization and cytotoxicity studies against A549 cell lines. J Drug Deliv Sci Technol. 2025;107:106805.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"2032_CR52","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3390\/pharmaceutics13122087","volume":"13","author":"NS Lotfy","year":"2021","unstructured":"Lotfy NS, Borg TM, Mohamed EA. The promising role of chitosan\u2013poloxamer 188 nanocrystals in improving diosmin dissolution and therapeutic efficacy against ferrous sulfate-induced hepatic injury in rats. Pharmaceutics. 2021;13(12):2087.","journal-title":"Pharmaceutics"},{"key":"2032_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejpb.2019.02.004","volume":"137","author":"S Soisuwan","year":"2019","unstructured":"Soisuwan S, Teeranachaideekul V, Wongrakpanich A, Langguth P, Junyaprasert VB. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals. Eur J Pharm Biopharm. 2019;137:68\u201376.","journal-title":"Eur J Pharm Biopharm"},{"key":"2032_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120395","volume":"598","author":"SS Kunde","year":"2021","unstructured":"Kunde SS, Wairkar S. Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy. Int J Pharm. 2021;598:120395.","journal-title":"Int J Pharm"},{"issue":"1","key":"2032_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.apsb.2022.03.026","volume":"13","author":"Z Luo","year":"2023","unstructured":"Luo Z, Wu S, Zhou J, Xu W, Xu Q, Lu L, et al. All-stage targeted therapy for the brain metastasis from triple-negative breast cancer. Acta Pharm Sin B. 2023;13(1):359\u201371.","journal-title":"Acta Pharm Sin B"},{"key":"2032_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213924","author":"FS Abou-Elnour","year":"2024","unstructured":"Abou-Elnour FS, El-Habashy SE, Essawy MM, Abdallah OY. Alendronate\/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia. Biomater Adv. 2024. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213924.","journal-title":"Biomater Adv"},{"issue":"15","key":"2032_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302074","volume":"13","author":"F Fontana","year":"2024","unstructured":"Fontana F, Molinaro G, Moroni S, Pallozzi G, Ferreira MP, Tello RP, et al. Biomimetic platelet-cloaked nanoparticles for the delivery of anti-inflammatory curcumin in the treatment of atherosclerosis. Adv Healthc Mater. 2024;13(15):2302074.","journal-title":"Adv Healthc Mater"},{"key":"2032_CR58","unstructured":"Quattrocchia N, Chiappinib C, Cooperc L, Ferraria M, Tasciottia E. A \u201cleukolike\u201d multistage delivery system to overcome biological barriers. in Nanotechnology 2010: Bio Sensors, Instruments, Medical, Environment and Energy-2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2010. 2010."},{"key":"2032_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0099-5428(08)60219-1","volume-title":"Analytical profiles of drug substances","author":"DW Fink","year":"1988","unstructured":"Fink DW. Ivermectin. In: Analytical profiles of drug substances. Elsevier; 1988. p. 155\u201384."},{"key":"2032_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jddst.2017.11.025","volume":"44","author":"A Tambe","year":"2018","unstructured":"Tambe A, Pandita N. Enhanced solubility and drug release profile of boswellic acid using a poloxamer-based solid dispersion technique. J Drug Deliv Sci Technol. 2018;44:172\u201380.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"2032_CR61","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijpharm.2015.05.070","volume":"490","author":"Y Li","year":"2015","unstructured":"Li Y, Zhao X, Zu Y, Zhang Y. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization. Int J Pharm. 2015;490(1\u20132):324\u201333.","journal-title":"Int J Pharm"},{"issue":"1","key":"2032_CR62","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41467-021-22311-z","volume":"12","author":"B Bahmani","year":"2021","unstructured":"Bahmani B, Gong H, Luk BT, Haushalter KJ, DeTeresa E, Previti M, et al. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors. Nat Commun. 2021;12(1):1999.","journal-title":"Nat Commun"},{"key":"2032_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2013.12.018","volume":"176","author":"Y Lu","year":"2014","unstructured":"Lu Y, Wang Z-H, Li T, McNally H, Park K, Sturek M. Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation. J Control Release. 2014;176:76\u201385.","journal-title":"J Control Release"},{"issue":"1","key":"2032_CR64","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2254530","volume":"30","author":"SA Elbanna","year":"2023","unstructured":"Elbanna SA, Ebada HM, Abdallah OY, Essawy MM, Abdelhamid HM, Barakat HS. Novel tetrahydrocurcumin integrated mucoadhesive nanocomposite \u03ba-carrageenan\/xanthan gum sponges: a strategy for effective local treatment of oral cancerous and precancerous lesions. Drug Deliv. 2023;30(1):2254530.","journal-title":"Drug Deliv"},{"key":"2032_CR65","volume":"12","author":"M Sulik","year":"2024","unstructured":"Sulik M, Otto-\u015alusarczyk D, Antoszczak M, Struga M, Huczy\u0144ski A. Ivermectin and its synthetic derivatives\u2013a new class of anticancer agents. Eur J Med Chem Rep. 2024;12:100176.","journal-title":"Eur J Med Chem Rep"},{"key":"2032_CR66","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00280-020-04041-z","volume":"85","author":"M Juarez","year":"2020","unstructured":"Juarez M, Schcolnik-Cabrera A, Dominguez-Gomez G, Chavez-Blanco A, Diaz-Chavez J, Duenas-Gonzalez A. Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Cancer Chemother Pharmacol. 2020;85:1153\u201363.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2032_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105207","volume":"163","author":"M Tang","year":"2021","unstructured":"Tang M, Hu X, Wang Y, Yao X, Zhang W, Yu C, et al. Ivermectin, a potential anticancer drug derived from an antiparasitic drug. Pharmacol Res. 2021;163:105207.","journal-title":"Pharmacol Res"},{"key":"2032_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119432","volume":"584","author":"Q Fu","year":"2020","unstructured":"Fu Q, Jin X, Zhang Z, Lv H. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS. Int J Pharm. 2020;584:119432.","journal-title":"Int J Pharm"},{"issue":"5","key":"2032_CR69","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1208\/s12248-015-9774-0","volume":"17","author":"Y Chen","year":"2015","unstructured":"Chen Y, Li T. Cellular uptake mechanism of paclitaxel nanocrystals determined by confocal imaging and kinetic measurement. AAPS J. 2015;17(5):1126\u201334.","journal-title":"AAPS J"},{"issue":"21","key":"2032_CR70","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.2174\/1381612824666180515154109","volume":"24","author":"M Fan","year":"2018","unstructured":"Fan M, Geng S, Liu Y, Wang J, Wang Y, Zhong J, et al. Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment. Curr Pharm Des. 2018;24(21):2416\u201324.","journal-title":"Curr Pharm Des"},{"key":"2032_CR71","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2023.08.057","volume":"362","author":"Y Liu","year":"2023","unstructured":"Liu Y, Qi Y, Chen C, Jin Y, Du S, Qiao J, et al. Platelet-mimetic nano-sensor for combating postoperative recurrence and wound infection of triple-negative breast cancer. J Control Release. 2023;362:396\u2013408.","journal-title":"J Control Release"},{"issue":"3","key":"2032_CR72","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2017.08.097","volume":"492","author":"M Zhu","year":"2017","unstructured":"Zhu M, Li Y, Zhou Z. Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage. Biochem Biophys Res Commun. 2017;492(3):373\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"2032_CR73","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","volume":"116","author":"S Sharmeen","year":"2010","unstructured":"Sharmeen S, Skrtic M, Sukhai MA, Hurren R, Gronda M, Wang X, et al. The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood. 2010;116(18):3593\u2013603.","journal-title":"Blood"},{"key":"2032_CR74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","volume":"229","author":"F Ravar","year":"2016","unstructured":"Ravar F, Saadat E, Gholami M, Dehghankelishadi P, Mahdavi M, Azami S, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10\u201322.","journal-title":"J Control Release"},{"issue":"3","key":"2032_CR75","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/molecules27030860","volume":"27","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang M, Lin F, Zhang X, Zhao Y, Guo C, et al. Preparation, characterization, and evaluation of liposomes containing oridonin from Rabdosia rubescens. Molecules. 2022;27(3):860.","journal-title":"Molecules"},{"key":"2032_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.024","volume":"206","author":"H Ye","year":"2019","unstructured":"Ye H, Wang K, Wang M, Liu R, Song H, Li N, et al. Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials. 2019;206:1\u201312.","journal-title":"Biomaterials"},{"issue":"10","key":"2032_CR77","first-page":"4502","volume":"12","author":"L Jiang","year":"2022","unstructured":"Jiang L, Sun Y-J, Song X-H, Sun Y-Y, Yang W-Y, Li J, et al. Ivermectin inhibits tumor metastasis by regulating the Wnt\/\u03b2-catenin\/integrin \u03b21\/FAK signaling pathway. Am J Cancer Res. 2022;12(10):4502.","journal-title":"Am J Cancer Res"},{"key":"2032_CR78","doi-asserted-by":"publisher","DOI":"10.14235\/bas.galenos.2022.54254","author":"EM G\u00fcler","year":"2023","unstructured":"G\u00fcler EM. Ivermectin induces oxidative stress and DNA damage in breast cancer cells. Bezmialem Sci. 2023. https:\/\/doi.org\/10.14235\/bas.galenos.2022.54254.","journal-title":"Bezmialem Sci"},{"issue":"3","key":"2032_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2016.10.064","volume":"480","author":"Y Liu","year":"2016","unstructured":"Liu Y, Fang S, Sun Q, Liu B. Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochem Biophys Res Commun. 2016;480(3):415\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"2032_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2020.108059","volume":"221","author":"TA Reis","year":"2021","unstructured":"Reis TA, Oliveira-da-Silva JA, Tavares GS, Mendon\u00e7a DV, Freitas CS, Costa RR, et al. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. Exp Parasitol. 2021;221:108059.","journal-title":"Exp Parasitol"},{"key":"2032_CR81","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S479438","author":"R Gao","year":"2024","unstructured":"Gao R, Lin P, Yang W, Fang Z, Gao C, Cheng B, et al. Bio-inspired nanodelivery platform: platelet membrane-cloaked genistein nanosystem for targeted lung cancer therapy. Int J Nanomed. 2024. https:\/\/doi.org\/10.2147\/IJN.S479438.","journal-title":"Int J Nanomed"},{"issue":"7","key":"2032_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11051-019-4580-8","volume":"21","author":"C Chi","year":"2019","unstructured":"Chi C, Li F, Liu H, Feng S, Zhang Y, Zhou D, et al. Docetaxel-loaded biomimetic nanoparticles for targeted lung cancer therapy in vivo. J Nanopart Res. 2019;21(7):144.","journal-title":"J Nanopart Res"},{"key":"2032_CR83","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S517753","author":"B Song","year":"2025","unstructured":"Song B, Na Y-G, Kim BJ, Jin M, Song YH, Kim D-E, et al. Platelet membrane-coated poly (lactic-co-glycolic acid) nanoparticles as a targeting drug delivery system for multidrug-resistant breast cancer. Int J Nanomedicine. 2025. https:\/\/doi.org\/10.2147\/IJN.S517753.","journal-title":"Int J Nanomedicine"},{"key":"2032_CR84","doi-asserted-by":"publisher","first-page":"10151","DOI":"10.2147\/IJN.S285952","volume":"15","author":"W Pei","year":"2020","unstructured":"Pei W, Huang B, Chen S, Wang L, Xu Y, Niu C. Platelet-mimicking drug delivery nanoparticles for enhanced chemo-photothermal therapy of breast cancer. Int J Nanomedicine. 2020;15:10151.","journal-title":"Int J Nanomedicine"},{"key":"2032_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.793006","volume":"11","author":"M Chen","year":"2021","unstructured":"Chen M, Wang P, Jiang D, Bao Z, Quan H. Platelet membranes coated gold nanocages for tumor targeted drug delivery and amplificated low-dose radiotherapy. Front Oncol. 2021;11:793006.","journal-title":"Front Oncol"},{"key":"2032_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biomaterials.2017.12.028","volume":"159","author":"L Xu","year":"2018","unstructured":"Xu L, Gao F, Fan F, Yang L. Platelet membrane coating coupled with solar irradiation endows a photodynamic nanosystem with both improved antitumor efficacy and undetectable skin damage. Biomaterials. 2018;159:59\u201367.","journal-title":"Biomaterials"},{"key":"2032_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105196","author":"W Gao","year":"2022","unstructured":"Gao W, Xiao L, Mu Y, Xiao Y. Targeting macrophage endocytosis via platelet membrane coating for advanced osteoimmunomodulation. iScience. 2022. https:\/\/doi.org\/10.1016\/j.isci.2022.105196.","journal-title":"iScience"},{"key":"2032_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.801662","volume":"12","author":"L Yuan","year":"2022","unstructured":"Yuan L, Cai Y, Zhang L, Liu S, Li P, Li X. Promoting apoptosis, a promising way to treat breast cancer with natural products: a comprehensive review. Front Pharmacol. 2022;12:801662.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2032_CR89","doi-asserted-by":"publisher","first-page":"16222","DOI":"10.1038\/srep16222","volume":"5","author":"D Draganov","year":"2015","unstructured":"Draganov D, Gopalakrishna-Pillai S, Chen Y-R, Zuckerman N, Moeller S, Wang C, et al. Modulation of P2X 4\/P2 X7\/Pannexin-1 sensitivity to extracellular ATP via ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep. 2015;5(1):16222.","journal-title":"Sci Rep"},{"issue":"2","key":"2032_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12543","volume":"52","author":"P Zhang","year":"2019","unstructured":"Zhang P, Zhang Y, Liu K, Liu B, Xu W, Gao J, et al. Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway. Cell Prolif. 2019;52(2):e12543.","journal-title":"Cell Prolif"},{"key":"2032_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123637","volume":"649","author":"NG Sallam","year":"2024","unstructured":"Sallam NG, Boraie NA, Sheta E, El-Habashy SE. Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil. Int J Pharm. 2024;649:123637.","journal-title":"Int J Pharm"},{"key":"2032_CR92","doi-asserted-by":"crossref","unstructured":"Yang Y, Cao Y. The impact of VEGF on cancer metastasis and systemic disease. In: Seminars in cancer biology. Elsevier; 2022.","DOI":"10.1016\/j.semcancer.2022.03.011"},{"issue":"12","key":"2032_CR93","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.3390\/cells9122648","volume":"9","author":"FI Montalto","year":"2020","unstructured":"Montalto FI, De Amicis F. Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells. 2020;9(12):2648.","journal-title":"Cells"},{"key":"2032_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102873","volume":"95","author":"MN Malak","year":"2025","unstructured":"Malak MN, Arafa EA, Abdel-Fattah MM, Khalaf MM, Arab HH, Hamzawy MA. Targeting EGFR\/PI3K\/AKT\/mTOR and Bax\/Bcl-2\/caspase3 pathways with ivermectin mediates its anticancer effects against urethane-induced non-small cell lung cancer in BALB\/c mice. Tissue Cell. 2025;95:102873.","journal-title":"Tissue Cell"},{"issue":"10","key":"2032_CR95","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.15252\/emmm.201404084","volume":"6","author":"A Melotti","year":"2014","unstructured":"Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A. The river blindness drug I vermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. EMBO Mol Med. 2014;6(10):1263\u201378.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"2032_CR96","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L. Turning cold into hot: firing up the tumor microenvironment. Trends Cancer. 2020;6(7):605\u201318.","journal-title":"Trends Cancer"},{"issue":"1","key":"2032_CR97","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41523-021-00229-5","volume":"7","author":"D Draganov","year":"2021","unstructured":"Draganov D, Han Z, Rana A, Bennett N, Irvine DJ, Lee PP. Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer. NPJ Breast Cancer. 2021;7(1):22.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"2032_CR98","doi-asserted-by":"publisher","first-page":"20.2.1","DOI":"10.1002\/0471142735.im2002s39","volume":"39","author":"BA Pulaski","year":"2000","unstructured":"Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol. 2000;39(1):20.2.1-20.2.16.","journal-title":"Curr Protoc Immunol"},{"key":"2032_CR99","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S142650","author":"Y Huang","year":"2018","unstructured":"Huang Y, Pan L, Helou K, Xia Q, Parris TZ, Li H, et al. Mechanical ventilation promotes lung metastasis in experimental 4T1 breast cancer lung-metastasized models. Cancer Manag Res. 2018. https:\/\/doi.org\/10.2147\/CMAR.S142650.","journal-title":"Cancer Manag Res"},{"key":"2032_CR100","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jconrel.2023.12.052","volume":"366","author":"J Zhu","year":"2024","unstructured":"Zhu J, Wang R, Yang C, Shao X, Zhang Y, Hou J, et al. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes. J Control Release. 2024;366:328\u201341.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02032-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:03:26Z","timestamp":1783519406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02032-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}